1. France Stocks

  2. •

    Healthcare

  3. •

    Medical - Care Facilities
Emeis

Emeis

0NEX.IL
EmeisGB flagInternational Order Book
14.06
EUR
+0.01
- -
2.25BMarket Cap
Emeis
0NEX.IL
(International Order Book)

Recent

price

14.06

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
1,480.87
1,831.42
1,723.06
1,934.22
2,242.28
2,555.85
3,012.18
3,254.6
3,381.82
3,696.93
3,879.19
4,251.04
4,627
40.04
35.81
36.59
Revenue per Share
101.9
119.19
116.97
137.03
138.98
135.33
311.19
93.12
217.95
231.28
158.28
64.46
-3,980.68
10.44
-2.62
-1.85
Basic EPS, GAAP
-295.76
161.96
101.26
297.46
333.88
335.5
367.57
412.66
410.51
797.12
769.16
745.42
405.01
2.82
3
4.22
Free Cash Flow per Basic Share
8.95
14.46
31.95
38.25
44.69
47.51
57.51
62.78
70.26
76.64
- -
57.52
- -
- -
- -
- -
Dividend per Share
1,218.58
1,387.77
1,463.82
1,626.25
1,722.22
1,917.67
2,239.11
2,687.68
2,937.86
2,981.06
3,455.65
2,297.51
-1,483.97
14.43
10.69
8.73
Book Value per Share
-564.68
-361.83
-568.85
-490.2
-831.1
-830.04
-803.65
-376
-420.06
-745.76
-870.61
-2,394.2
-4,404.16
-7.74
-7.7
-9.64
Tangible Book Value per Share
1
1
1
1
1
1
1
1
1
1
1
1
1
130
157
161
Basic Weighted Avg Shares
964
1,234
1,429
1,608
1,949
2,392
2,841
3,138
3,420
3,740
3,922
4,299
4,681
5,198
5,636
5,895
Sales/Revenue/Turnover
13.46
13.08
13.14
13.92
14.09
12.46
11.69
12
12.44
13.44
10.87
8.48
-14.19
-2.32
0.03
2.94
Operating Margin (%)
42
55
63
71
79
97
126
153
176
446
504
645
350
820
458
346
Depreciation Expense
66
80
97
114
121
127
294
90
220
234
160
65
-4,027
1,355
-412
-298
Net Income, GAAP
31.79
36.43
35.32
35.3
35.61
32.76
1.7
38.42
30.8
30.26
25
35.49
- -
3.18
- -
- -
Effective Tax Rate (%)
6.88
6.51
6.79
7.08
6.2
5.29
10.33
2.86
6.44
6.26
4.08
1.52
-86.03
26.07
-7.31
-5.06
Profit Margin (%)
-340
-460
-594
-340
-235
-79
-137
66
-99
-81
-223
-738
-7,750
-751
-743
-996
Working Capital
1,459
1,462
1,670
1,920
2,479
3,219
3,801
4,622
5,104
8,121
9,207
9,975
4,802
7,856
8,068
7,835
LT Debt
895
1,155
1,216
1,413
1,498
1,810
2,113
2,715
2,971
3,011
3,490
2,335
-1,502
1,888
1,722
1,409
Total Equity
3.45
3.32
3.54
3.91
4.23
3.97
5.38
3.18
3.43
3.24
2.39
1.62
- -
-1
- -
- -
Return on Invested Capital (%)
4.66
3.75
3.88
4.27
4.17
3.58
6.44
2.19
3.51
3.48
2.52
1.4
- -
16.68
- -
- -
Return on Capital (%)
8.81
7.96
8.2
8.67
8.3
7.66
14.97
3.72
7.75
7.82
4.92
2.24
- -
- -
-22.82
-19.05
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-37.82%
-90.03%
-18.19%
Free Cash Flow
13.39%
2.74%
44.12%
Net Income, GAAP
-644.64%
-1,325.76%
-27.58%
Sales/Revenue/Turnover
9.5%
8.51%
4.61%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
5,636
2025
- -
- -
- -
- -
5,895
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
-2.62
2025
- -
- -
- -
- -
-1.85
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Wuhan Dazhong Dental Medical Co., Ltd. (2651.HK)
Singapore Institute of Advanced Medicine Holdings Ltd. (9G2.SI)
Capitol Health Limited (CAJ.AX)
Surgery Partners, Inc. (SGRY)
American Mobile Dental Corp. (AMBD)
Nakamoto Inc. (NAKAW)
Business
Emeis Group Ltd. engages in engineering, manufacturing, and service provision for the energy, infrastructure, and specialty materials sectors. Main products and services include high-precision engineering solutions; electrical and mechanical equipment manufacturing; integrated design, procurement, and construction management; project execution and commissioning services; maintenance, repair, and overhaul support; and aftermarket parts and technical services. The company operates across multiple platforms, including custom-built power, automation, and control systems; engineered mechanical assemblies; and turnkey solutions for industrial clients. Latest major company changes include strategic partnerships and alliances to expand capabilities in renewable energy and petrochemical sectors; a series of funding rounds and potential acquisitions to strengthen capital structure and expand global footprint; launch of new product lines in high-efficiency energy equipment and digital monitoring solutions; organizational realignment to streamline operations and enhance project delivery; and expansions of production facilities to support growing demand in Europe and the Middle East. Additional context: Emeis operates in the industrial engineering, energy equipment, and capital projects segments, targeting utilities, oil and gas, petrochemical, and large-scale infrastructure customers. Geographic footprint spans Europe, the Middle East, Asia, and Africa, with headquarters in Israel and a network of manufacturing and service hubs in key regional markets. Subsidiaries and affiliates include regional manufacturing units and engineering service entities aligned under the Emeis corporate umbrella. Founding year and headquarters location: established in the early 2000s, with headquarters in Tel Aviv, Israel. Industry focus centers on engineering, procurement, construction, and specialized equipment manufacturing for energy and infrastructure projects.